<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2022-12-4-302-309</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-1483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Симптоматика в отдаленном периоде после перенесенной коронавирусной инфекции: результаты длительного наблюдения</article-title><trans-title-group xml:lang="en"><trans-title>Symptoms in the Long Period after the Coronavirus Infection: Results of Long-Term Follow-Up</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1637-2402</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мелехов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Melekhov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7559-135X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Агаева</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Agaeva</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1699-0881</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитин</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitin</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра госпитальной терапии им. Г.И. Сторожакова лечебного факультета Российского национального исследовательского медицинского университета&#13;
им. Н.И. Пирогова; Федеральное государственное автономное учреждение «Национальный&#13;
медицинский исследовательский центр «Лечебно-реабилитационный центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Deparment of Internal disease named after G.I. Storozhakov of the medical faculty of Pirogov Russian National Research Medical University named after N.I. Pirogov;  Federal State Autonomous Institution «National Medical Research Center of Treatment and Rehabilitation» оf the Russian Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кафедра госпитальной терапии им. Г.И. Сторожакова лечебного факультета Российского национального исследовательского медицинского университета&#13;
им. Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Deparment of Internal disease named after G.I. Storozhakov of the medical faculty of Pirogov Russian National Research Medical University named after N.I. Pirogov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Кафедра госпитальной терапии им. Г.И. Сторожакова лечебного факультета Российского национального исследовательского медицинского университета&#13;
им. Н.И. Пирогова; Федеральное государственное автономное учреждение «Национальный медицинский исследовательский центр «Лечебно-реабилитационный центр» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Deparment of Internal disease named after G.I. Storozhakov of the medical faculty of Pirogov Russian National Research Medical University named after N.I. Pirogov;  Federal State Autonomous Institution «National Medical Research Center of Treatment and Rehabilitation»of the Russian Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>31</day><month>07</month><year>2022</year></pub-date><volume>12</volume><issue>4</issue><fpage>302</fpage><lpage>309</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мелехов А.В., Агаева А.И., Никитин И.Г., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Мелехов А.В., Агаева А.И., Никитин И.Г.</copyright-holder><copyright-holder xml:lang="en">Melekhov A.V., Agaeva A.I., Nikitin I.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/1483">https://www.medarhive.ru/jour/article/view/1483</self-uri><abstract><sec><title>Введение</title><p>Введение: данные о виде, частоте и продолжительности остаточных симптомов после COVID-19 неоднородны, что связано с методологическими особенностями проведения исследований. Цель: оценка частоты и выраженности симптомов в отдаленном периоде после перенесенной новой коронавирусной инфекции.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: Проведен телефонный опрос пациентов, госпитализированных в ЛРЦ МЗ РФ в связи с COVID-19 в период 13.04.2020-10.06.2020: 195 пациентов (58,2 % выписанных) через 143 (131-154) дней после дебюта заболевания и 183 (54,6 % выписанных) через 340 (325-351) дней.</p></sec><sec><title>Результаты</title><p>Результаты: Субъективная оценка состояния своего здоровья по 100-балльной шкале до и после перенесенного COVID-19 на первом опросе составила 95 (80-100) и 80 (70-96) баллов (p&lt; 0,001 для сравнении оценки до и после заболевания), на втором — 90 (80-100) и 80 (60-90) баллов, (p&lt; 0,001 для сравнении оценки до и после заболевания и для сравнения оценки состояния здоровья после COVID-19 на двух этапах опроса). Разнообразные жалобы выявлены у 63 % опрошенных на первом этапе и у 75 % — на втором, количество выявленных симптомов составило 2 (0-6) и 4 (1-8) соответственно. Наиболее частыми жалобами были слабость/утомляемость (31,3 и 47,5 % опрошенных), боли в суставах (31,3 и 47,5 %) и одышка/чувство нехватки воздуха (31,3 и 43,2 %). Рост этих показателей можно связывать с изменением методики опроса. Выраженность лидир ующих симптомов на втором опросе при оценке по десятибалльной шкале была низкой: утомляемость 3 (0-6) баллов, боль в суставах, слабость и одышка — 0 (0-5) баллов, чувство нехватки воздуха — 0(0-3) балла.</p></sec><sec><title>Заключение</title><p>Заключение: снижение самочувствия сохраняется в течение длительного времени после перенесенной коронавирусной инфекции у значительной доли пациентов, однако выраженность лидирующих симптомов к 12 месяцу наблюдения достаточно низка.</p></sec></abstract><trans-abstract xml:lang="en"><p>Background: assessment of type, prevalence and duration of residual symptoms after COVID-19 in recent studies is controversial because of differences in design. Aim: to assess the prevalence and severity of symptoms in the long-term period after COVID-19. Materials and methods: patients hospitalized with COVID-19 in the period 13.04.2020-10.06.2020 were interviewed by phone: 195 (58,2 %) convalescents at 143 (131-154) days after disease onset and 183 (54,6 % ) of them at 340 (325-351) days. Results: The subjective assessment of health status with 100-point scale before and after the COVID-19 was 95 (80-100) and 80 (70-96) points, p&lt; 0,001, at first interview; 90 (80-100) and 80 (60-90) points, p&lt; 0,001, at second one. Various complaints were detected in 63 % of respondents at the first interview and in 75 % at the second, the number of identified symptoms was 2 (0-6) and 4 (1-8) respectively. The most frequent complaints were weakness/fatigue (31.3 and 47.5 % of respondents), joint pain (31.3 and 47.5 %) and dyspnoe/shortness of breath (31.3 and 43.2 %). The growth of these indicators can be associated with a change in the interview methodology. The severity of the symptoms at second interview was low: fatigue — 3 (0-6) points, shortness of breath — 0 (0-3) points; joint pain, weakness and dyspnoe — 0 (0-5) points each. Conclusion: a decrease of health status can sustain for a long time after COVID-19. Symptoms persist in a significant proportion of convalescents, but their severity in the end of follow-up is quite low.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>последствия коронавирусной инфекции</kwd><kwd>постковид</kwd><kwd>выраженность симптомов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>long covid</kwd><kwd>post-covid</kwd><kwd>severity of symptoms</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993-998. Published 2020 Jul 31. doi:10.15585/mmwr. mm6930e1</mixed-citation><mixed-citation xml:lang="en">Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993-998. Published 2020 Jul 31. doi:10.15585/mmwr. mm6930e1</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Halpin SJ, McIvor C, Whyatt G et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A crosssectional evaluation. J Med Virol. 2021 Feb; 93(2): 1013-1022. doi: 10.1002/jmv.26368.</mixed-citation><mixed-citation xml:lang="en">Halpin SJ, McIvor C, Whyatt G et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A crosssectional evaluation. J Med Virol. 2021 Feb; 93(2): 1013-1022. doi: 10.1002/jmv.26368.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mandal S, Barnett J, Brill SE, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021 Apr; 76(4):396-398. doi: 10.1136/thoraxjnl-2020-215818.</mixed-citation><mixed-citation xml:lang="en">Mandal S, Barnett J, Brill SE, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021 Apr; 76(4):396-398. doi: 10.1136/thoraxjnl-2020-215818.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021 Feb;27(2):258-263. doi: 10.1016/j. cmi.2020.09.052.</mixed-citation><mixed-citation xml:lang="en">Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021 Feb;27(2):258-263. doi: 10.1016/j. cmi.2020.09.052.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603</mixed-citation><mixed-citation xml:lang="en">Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021 Jan 7;31:100683. doi: 10.1016/j. eclinm.2020.100683.</mixed-citation><mixed-citation xml:lang="en">Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021 Jan 7;31:100683. doi: 10.1016/j. eclinm.2020.100683.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j. jinf.2021.01.004.</mixed-citation><mixed-citation xml:lang="en">Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j. jinf.2021.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the postCOVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. doi: 10.1183/23120541.00542-2020.</mixed-citation><mixed-citation xml:lang="en">Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the postCOVID-19 syndrome? ERJ Open Res. 2020 Oct 26;6(4):00542-2020. doi: 10.1183/23120541.00542-2020.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Venturelli S, Benatti SV, Casati M, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021 Jan 19;149:e32. doi: 10.1017/S0950268821000145.</mixed-citation><mixed-citation xml:lang="en">Venturelli S, Benatti SV, Casati M, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021 Jan 19;149:e32. doi: 10.1017/S0950268821000145.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sathyamurthy P, Madhavan S, Pandurangan V. Prevalence, Pattern and Functional Outcome of Post COVID-19 Syndrome in Older Adults. Cureus. 2021 Aug 15;13(8):e17189. doi: 10.7759/cureus.17189</mixed-citation><mixed-citation xml:lang="en">Sathyamurthy P, Madhavan S, Pandurangan V. Prevalence, Pattern and Functional Outcome of Post COVID-19 Syndrome in Older Adults. Cureus. 2021 Aug 15;13(8):e17189. doi: 10.7759/cureus.17189</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Liang L, Yang B, Jiang N, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020 Dec 7;35(47):e418. doi: 10.3346/jkms.2020.35.e418.</mixed-citation><mixed-citation xml:lang="en">Liang L, Yang B, Jiang N, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020 Dec 7;35(47):e418. doi: 10.3346/jkms.2020.35.e418.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kashif A, Chaudhry M, Fayyaz T, et al. Follow-up of COVID-19 recovered patients with mild disease. Sci Rep. 2021 Jun 28; 11(1):13414. doi: 10.1038/s41598-021-92717-8.</mixed-citation><mixed-citation xml:lang="en">Kashif A, Chaudhry M, Fayyaz T, et al. Follow-up of COVID-19 recovered patients with mild disease. Sci Rep. 2021 Jun 28; 11(1):13414. doi: 10.1038/s41598-021-92717-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bellan M, Soddu D, Balbo PE, et al. Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021 Jan 4;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</mixed-citation><mixed-citation xml:lang="en">Bellan M, Soddu D, Balbo PE, et al. Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021 Jan 4;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi:10.1016/j.jinf.2020.08.029</mixed-citation><mixed-citation xml:lang="en">Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi:10.1016/j.jinf.2020.08.029</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Stavem K, Ghanima W, Olsen MK, et al. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021 Apr;76(4):405-407. doi: 10.1136/thoraxjnl-2020-216377.</mixed-citation><mixed-citation xml:lang="en">Stavem K, Ghanima W, Olsen MK, et al. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021 Apr;76(4):405-407. doi: 10.1136/thoraxjnl-2020-216377.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis A, Wamil M, Alberts J, et al. COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.</mixed-citation><mixed-citation xml:lang="en">Dennis A, Wamil M, Alberts J, et al. COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021 Mar 30;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gautam N, Madathil S, Tahani N, et al. Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection. Clin Infect Dis. 2021 Apr 24:ciab341. doi: 10.1093/cid/ciab341.</mixed-citation><mixed-citation xml:lang="en">Gautam N, Madathil S, Tahani N, et al. Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection. Clin Infect Dis. 2021 Apr 24:ciab341. doi: 10.1093/cid/ciab341.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140- 6736(20)32656-8.</mixed-citation><mixed-citation xml:lang="en">Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140- 6736(20)32656-8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yomogida, K., Zhu, S., Rubino, F., et al. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years — Long Beach, California, April 1-December 10, 2020. MMWR. Morbidity and mortality weekly report, 70(37), 1274–1277. https://doi. org/10.15585/mmwr.mm7037a2</mixed-citation><mixed-citation xml:lang="en">Yomogida, K., Zhu, S., Rubino, F., et al. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years — Long Beach, California, April 1-December 10, 2020. MMWR. Morbidity and mortality weekly report, 70(37), 1274–1277. https://doi. org/10.15585/mmwr.mm7037a2</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j. eclinm.2021.101019.</mixed-citation><mixed-citation xml:lang="en">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j. eclinm.2021.101019.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, et al. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J Clin Med. 2021;10(13):2945. doi:10.3390/jcm10132945</mixed-citation><mixed-citation xml:lang="en">Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, et al. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. J Clin Med. 2021;10(13):2945. doi:10.3390/jcm10132945</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of postacute sequelae of COVID-19. Nature. 2021 Jun;594(7862):259-264. doi: 10.1038/s41586-021-03553-9.</mixed-citation><mixed-citation xml:lang="en">Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of postacute sequelae of COVID-19. Nature. 2021 Jun;594(7862):259-264. doi: 10.1038/s41586-021-03553-9.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. и др. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARSCoV-2)». Предварительные данные (6 месяцев наблюдения). Российский кардиологический журнал. 2021; 26(10):4 708. doi:10.15829/1560-4071-2021-4708.</mixed-citation><mixed-citation xml:lang="en">Peluso MJ, Kelly JD, Lu S, et al. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv [Preprint]. 2021 Mar 12:2021.03.11.21252311. doi: 10.1101/20 21.03.11.21252311.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Peluso MJ, Kelly JD, Lu S, et al. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv [Preprint]. 2021 Mar 12:2021.03.11.21252311. doi: 10.1101/20 21.03.11.21252311.</mixed-citation><mixed-citation xml:lang="en">Bergwerk M, Gonen T, Lustig Y, et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Bergwerk M, Gonen T, Lustig Y, et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072.</mixed-citation><mixed-citation xml:lang="en">Bergwerk M, Gonen T, Lustig Y, et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
